On June 15, 2022, the Supreme Court of the United States ruled unanimously in favor of several hospital groups concluding that the Department of Health and Human Services (HHS) exceeded its statutory authority by implementing a discriminatory... Read More
340B Covered Entity and Contract Pharmacy Regulatory and Contract Support | Articles | Healthcare Litigation | Hospitals and Healthcare Systems | Medicare and Insurance Audits

On April 4, 2022, U.S. District Judge Bernard M. Jones invalidated parts of Oklahoma’s Patient’s Right to Pharmacy Choice Act (the “Act”) in PCMA v. Mulready et al. concluding that certain provisions in the law were preempted under Medicare... Read More
Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Life Sciences | Medicare, Medicaid, and Other Commercial Payor Audits & Appeals | Pharmacy Law

On March 24, 2022, Senators Richard Pan and Scott Wiener of California introduced new legislation (SB-939) targeting abusive Pharmacy Benefit Manager (PBM) practices in connection with the federal 340B program. By way of background, the 340B program... Read More
340B Covered Entity and Contract Pharmacy Regulatory and Contract Support | Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law

On February 23, 2022, Michigan Governor Gretchen Whitmer signed into law House Bills 4348, 4351, and 4352, each tailored to address Pharmacy Benefit Managers’ (PBMs) discriminatory treatment of 340B entities. The signing of these Bills comes less... Read More
340B Covered Entity and Contract Pharmacy Regulatory and Contract Support | Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Defending Pharmacies in PBM Audits | Life Sciences | Maximum Allowable Cost Pricing & Appeals | Pharmacy Law | Plan Sponsor PBM Contract Services | Section 340B In-House and Contract Pharmacies

On March 7, 2022, Senator Vin Gopal introduced Senate Bill 2221 (“S2221”) with the goal of establishing transparency standards and licensing requirements for pharmacy benefit managers (“PBMs”) operating in New Jersey. Senate Bill S2221... Read More
Articles | Chain Pharmacies | Community, Retail Pharmacies | Digital Pharmacies | Life Sciences | Maximum Allowable Cost Pricing & Appeals | Pharmacy Law | Plan Sponsor PBM Contract Services

On October 26, 2021, Delaware’s new law regulating PBMs took effect. The law, HB219, regulates PBMs in multiple ways, and Insurance Commissioner Trinidad Navarro recently made a statement confirming that the Delaware Department of Insurance will... Read More
Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | DIR Fees | Life Sciences | Maximum Allowable Cost Pricing & Appeals | Pharmacy Law | Specialty Pharmacies | Supermarket Pharmacies | White Collar Criminal Defense & Government Investigations

The New York Legislature recently passed legislation which it has now sent to the Governor, Kathy Hochul, for signature. If signed, the “Pharmacy Rescue Package” will provide new opportunities for NY-based pharmacies and will provide much-needed... Read More
Articles | Chain Pharmacies | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Digital Pharmacies | Life Sciences | Long-Term Care Pharmacies | MAC Pricing & Appeals | News | Pharmacy Law | Plan Sponsor PBM Contract Services

Effective on January 1, 2022, the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) will implement the Final Rule for Medicare and Medicaid Programs. The Final Rule establishes pharmacy... Read More
Articles | Chain Pharmacies | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Pharmacy Transactions | Plan Sponsor PBM Contract Services